School of Engineering and Materials Science, Queen Mary University of London, Mile End Road, London, E1 4NS, UK.
Arthritis Res Ther. 2010;12(3):R82. doi: 10.1186/ar3009. Epub 2010 May 12.
The present study examined the effect of collagen fragments on anabolic and catabolic activities by chondrocyte/agarose constructs subjected to dynamic compression.
Constructs were cultured under free-swelling conditions or subjected to continuous and intermittent compression regimes, in the presence of the N-terminal (NT) and C-terminal (CT) telopeptides derived from collagen type II and/or 1400 W (inhibits inducible nitric oxide synthase (iNOS)). The anabolic and catabolic activities were compared to the amino-terminal fibronectin fragment (NH2-FN-f) and assessed as follows: nitric oxide (NO) release and sulphated glycosaminoglycan (sGAG) content were quantified using biochemical assays. Tumour necrosis factor-alpha (TNFalpha) and interleukin-1beta (IL-1beta) release were measured by ELISA. Gene expression of matrix metalloproteinase-3 (MMP-3), matrix metalloproteinase-13 (MMP-13), collagen type II and fibronectin were assessed by real-time quantitative polymerase chain reaction (qPCR). Two-way ANOVA and the post hoc Bonferroni-corrected t-test was used to examine data.
The presence of the NT or CT peptides caused a moderate to strong dose-dependent stimulation of NO, TNFalpha and IL-1beta production and inhibition of sGAG content. In some instances, high concentrations of telopeptides were just as potent in stimulating catabolic activities when compared to NH2-FN-f. Depending on the concentration and type of fragment, the increased levels of NO and cytokines were inhibited with 1400 W, resulting in the restoration of sGAG content. Depending on the duration and type of compression regime employed, stimulation with compression or incubation with 1400 W or a combination of both, inhibited telopeptide or NH2-FN-f induced NO release and cytokine production and enhanced sGAG content. All fragments induced MMP-3 and MMP-13 expression in a time-dependent manner. This effect was reversed with compression and/or 1400 W resulting in the restoration of sGAG content and induction of collagen type II and fibronectin expression.
Collagen fragments containing the N- and C-terminal telopeptides have dose-dependent catabolic activities similar to fibronectin fragments and increase the production of NO, cytokines and MMPs. Catabolic activities were downregulated by dynamic compression or by the presence of the iNOS inhibitor, linking reparative activities by both types of stimuli. Future investigations which examine the signalling cascades of chondrocytes in response to matrix fragments with mechanical influences may provide useful information for early osteoarthritis treatments.
本研究通过软骨细胞/琼脂糖构建体的动态压缩,考察了胶原蛋白片段对合成代谢和分解代谢活性的影响。
在存在 II 型胶原 N 端(NT)和 C 端(CT)肽段和/或 1400W(抑制诱导型一氧化氮合酶(iNOS))的情况下,使构建体在自由膨胀条件下或连续和间歇压缩条件下培养。将合成代谢和分解代谢活性与氨基末端纤维连接蛋白片段(NH2-FN-f)进行比较,并通过以下方式进行评估:使用生化测定法定量测定一氧化氮(NO)释放和硫酸化糖胺聚糖(sGAG)含量。通过 ELISA 测量肿瘤坏死因子-α(TNFalpha)和白细胞介素-1β(IL-1beta)的释放。通过实时定量聚合酶链反应(qPCR)评估基质金属蛋白酶-3(MMP-3)、基质金属蛋白酶-13(MMP-13)、II 型胶原和纤维连接蛋白的基因表达。使用双因素方差分析和事后 Bonferroni 校正 t 检验检查数据。
NT 或 CT 肽的存在导致 NO、TNFalpha 和 IL-1beta 产生的剂量依赖性刺激和 sGAG 含量的抑制,在某些情况下,高浓度的肽段在刺激分解代谢活性方面与 NH2-FN-f 一样有效。根据片段的浓度和类型,1400W 抑制了 NO 和细胞因子水平的升高,从而恢复了 sGAG 含量。根据所采用的压缩持续时间和类型,通过压缩或孵育 1400W 或两者的组合,抑制了肽段或 NH2-FN-f 诱导的 NO 释放和细胞因子产生,并增强了 sGAG 含量。所有片段均以时间依赖性方式诱导 MMP-3 和 MMP-13 的表达。通过压缩和/或 1400W 抑制这种作用,恢复了 sGAG 含量并诱导了 II 型胶原和纤维连接蛋白的表达。
含有 N 端和 C 端肽段的胶原蛋白片段具有类似纤维连接蛋白片段的剂量依赖性分解代谢活性,并增加了 NO、细胞因子和 MMP 的产生。通过动态压缩或存在 iNOS 抑制剂,可下调分解代谢活性,将这两种类型的刺激与修复活性联系起来。未来的研究,检查软骨细胞对基质片段的信号转导与机械影响,可能为早期骨关节炎治疗提供有用的信息。